Invention Grant
US09278096B2 Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity
有权
具有组合SERT，5-HT3和5-HT1A活性的化合物的治疗用途
- Patent Title: Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity
- Patent Title (中): 具有组合SERT，5-HT3和5-HT1A活性的化合物的治疗用途
-
Application No.: US12741780Application Date: 2008-11-12
-
Publication No.: US09278096B2Publication Date: 2016-03-08
- Inventor: Marianne Dragheim
- Applicant: Marianne Dragheim
- Applicant Address: DK Valby US IL Deerfield
- Assignee: H. Lundbeck A/S,Takeda Pharmaceuticals North America, Inc.
- Current Assignee: H. Lundbeck A/S,Takeda Pharmaceuticals North America, Inc.
- Current Assignee Address: DK Valby US IL Deerfield
- Agency: Fish & Richardson P.C.
- Priority: DK200701607 20071113; DK200701788 20071214; DK200801300 20080917
- International Application: PCT/DK2008/050271 WO 20081112
- International Announcement: WO2009/062517 WO 20090522
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A61K31/495
Abstract:
New pharmaceutical uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof are provided.
Public/Granted literature
- US20110201617A1 Therapeutic Uses Of Compounds Having Combined SERT, 5-HT3 And 5-HT1A Activity Public/Granted day:2011-08-18
Information query
IPC分类:
